BeyondSpring is Biotechnology in United States that focus on clinical stage business. Founded in 2013. They cover business area such as BeyondSpring Inc, clinical stage biopharmaceutical activity, cancer therapy, immuno-oncology agent, Plinabulin, marine, small-molecule, a number, distinct biological activity, multiple therapeutic opportunity, neutrophil, a type, white blood cell, bacterial infection, clinical resource, China.
2013
( 11 years old in 2024 )
Clinical Stage
-
28 Liberty Street
39th Floor
New York, NY 10005
United States
Private
BeyondSpring Incclinical stage biopharmaceutical activitycancer therapyimmuno-oncology agentPlinabulinmarinesmall-moleculea numberdistinct biological activitymultiple therapeutic opportunityneutrophila typewhite blood cellbacterial infectionclinical resourceChina
* We use standard office opening hours in near BeyondSpring's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BeyondSpring is Biotechnology business from United States that founded in 2013 (11 years old in 2024), BeyondSpring business is focusing on Clinical Stage.
BeyondSpring headquarter office and corporate office address is located in 28 Liberty Street 39th Floor New York, NY 10005 United States.
BeyondSpring was founded in United States.
In 2024, BeyondSpring is currently focus on clinical stage sector.
Above is snippet of Google Trends for "clinical stage" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BeyondSpring, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.